Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 4 Next >
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
Tickers RHHBF RHHBY RHHVF
Tags Market News News FDA
From Benzinga
A Harvard nutritional psychiatrist shares the 5 foods she eats to sharpen brain health, memory and focus
Tags Alzheimer's disease Make It / Money Healthy eating
From CNBC.com News
Cassava Sciences Starts Late-Stage Simufilam Study In Alzheimer's Patients
Tickers SAVA
Tags Trading Ideas Movers SAVA
From Benzinga
See Why Alzamend Neuro Stock Is Rallying On Thursday
Tickers ALZN
Tags News Market News why it's moving
From Benzinga
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags ESALY General Benzinga
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
Tickers BIIB
Tags Benzinga Needham BIIB
From Benzinga
B. Riley Says Alzheimer's Data From This Firm Has Renewed 'Investor Confidence'
Tickers SAVA
Tags News Reiteration Market News
From Benzinga
Cassava Sciences' Simufilam Data Shows Improved Cognition In Alzheimer's Disease
Tickers SAVA
Tags Benzinga Long Ideas Briefs
From Benzinga
Cassava CEO Goes Offensive Over Data Allegations
Tickers SAVA
Tags Benzinga Briefs Biotech
From Benzinga
Congress Asks For Approval Documents Of Biogen's Alzheimer's Drug: Report
Tickers BIIB
Tags Benzinga BIIB Briefs
From Benzinga
What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm
Tickers ACIU
Tags Phase 2 Trial News Analyst Color
From Benzinga
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
Tickers ACIU RHHBF RHHBY RHHVF
Tags why it's moving Market News News
From Benzinga
Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free
Tickers BIIB ESALF ESALY
Tags News ESALF Market News
From Benzinga
Cassava Sciences Shares Sink With Alzheimer's Drug Mired In Controversy
Tickers SAVA
Tags Alzheimer's disease Market News News
From Benzinga
Responses to Questions and Comments: August 2021
Tags Dr/ Dale Bredesen coronavirus Cancer
From Stock Gumshoe
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
Tickers BIIB ESALF ESALY
Tags News Market News ESALF
From Benzinga
AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration
Tickers ABBV
Tags Parkinson’s Disease ABBV News
From Benzinga
Hoth Therapeutics Starts Preclinical Study For Its Alzheimer's Candidate
Tickers HOTH
Tags Alzheimer's disease Health Care Market News
From Benzinga
I-Mab To Start Testing Alzheimer's Candidate In Human Trials
Tickers IMAB
Tags Biotech Briefs Benzinga
From Benzinga
Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease
Tickers LLY
Tags News Health Care LLY
From Benzinga
Annovis Bio Shares Cut In Half Following Alzheimer's Data Presentation
Tickers ANVS BIIB
Tags Alzheimer's disease Health Care Movers
From Benzinga
Anavex Life's Stock Declines Despite Data Shows Alzheimer's Candidate Prevent Abeta-Induced Cognitive Decline In Animal Study
Tickers AVXL
Tags Benzinga Briefs Biotech
From Benzinga
After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate
Tickers BIIB IONS
Tags General Benzinga Briefs
From Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
Tickers BIIB ESALF ESALY
Tags ESALY Benzinga General
From Benzinga
Synaptogenix Stock Drops After Unveiling Analyses Of Alzheimer's Candidate
Tickers ABBV SNPX
Tags General SNPX News
From Benzinga
Alzamend Neuro Stock Shoots Higher As Alzheimer's Candidate Shows Encouraging Safety Profile In Animal Models
Tickers ALZN
Tags Briefs Biotech Long Ideas
From Benzinga
Roche Puts Alzheimer's Candidate, Gantenerumab In Spotlight; In Dialogue with FDA: Reuters
Tickers RHHBF RHHBY RHHVF
Tags Market News News FDA
From Benzinga
Annovis Bio's Alzheimer's Candidate To Proceed Into Final Cohort Of Mid-Stage Study, Data Expected In 2022
Tickers ANVS
Tags Health Care Alzheimer's disease Small Cap
From Benzinga
Alzheimer’s in 2021: Plus ça Change, Plus C’est le Même Chose
Tags supplements Biogen Idec (BIIB) Doc Gumshoe
From Stock Gumshoe
INmune Bio Issues Equity Raise Of $40M At 18% Discount To Fund Alzheimer's Candidate Development
Tickers INMB
Tags Benzinga Biotech Briefs
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.